US Stock MarketDetailed Quotes

ACAD ACADIA Pharmaceuticals

Watchlist
  • 14.860
  • -0.320-2.11%
Close May 14 16:00 ET
  • 14.870
  • +0.010+0.07%
Pre 08:00 ET
2.46BMarket Cap0.00P/E (TTM)

ACADIA Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
262.15%29.08M
114.65%16.7M
457.97%85.39M
-8,009.35%-58.96M
162.48%8.2M
76.51%-17.93M
9.25%-114.04M
-3.17%-23.85M
95.74%-727K
48.18%-13.13M
Net income from continuing operations
138.48%16.56M
71.62%-61.29M
209.76%45.8M
-139.77%-65.18M
103.28%1.11M
61.95%-43.02M
-28.66%-215.98M
3.18%-41.73M
-88.03%-27.18M
22.47%-34.01M
Operating gains losses
----
-29.45%-4.59M
--0
30.94%-1.49M
150.30%1.24M
-1,180.24%-4.34M
-52.08%-3.54M
4.87%-1.54M
-462.92%-2.16M
379.21%497K
Depreciation and amortization
1,197.65%5.53M
174.04%5.55M
234.76%1.64M
240.51%1.72M
242.91%1.77M
-17.44%426K
-39.41%2.03M
-8.60%489K
-48.63%506K
-44.56%515K
Change In working capital
-136.03%-5.97M
-52.27%18.13M
228.66%21.71M
-196.11%-10.56M
-1,198.92%-9.59M
-21.65%16.56M
253.04%37.99M
-12.43%6.61M
156.77%10.98M
84.29%-738K
-Change in receivables
131.67%2.27M
-1,834.54%-39.27M
-12.59%-7.82M
-181.36%-10.38M
-157.19%-13.91M
-485.07%-7.17M
115.03%2.26M
-88.90%-6.94M
229.50%12.75M
-197.07%-5.41M
-Change in inventory
-3,561.12%-16.65M
-1,292.88%-28.81M
-4,960.32%-15.07M
-1,853.44%-11.22M
-574.68%-3M
-42.26%481K
157.36%2.42M
42.86%310K
118.03%640K
263.73%632K
-Change in prepaid assets
-64.28%-3.67M
-809.42%-17.69M
-171.54%-1.14M
-588.63%-14.06M
-105.48%-263K
-19.91%-2.23M
38.40%2.49M
118.49%1.6M
-228.85%-2.04M
108.01%4.8M
-Change in payables and accrued expense
-52.09%13.98M
224.65%97.97M
367.66%43.37M
2,431.65%21.66M
316.74%3.75M
23.86%29.19M
399.60%30.18M
16.51%9.27M
87.22%-929K
87.52%-1.73M
-Change in other current assets
1.91%1.76M
-12.00%5.74M
-57.06%739K
5.05%1.71M
-5.21%1.56M
13.40%1.73M
3.51%6.52M
15.35%1.72M
7.83%1.63M
-2.88%1.65M
-Change in other current liabilities
32.50%-3.66M
103.42%201K
150.69%1.63M
262.35%1.73M
431.14%2.27M
-13.54%-5.43M
-64.18%-5.88M
-20.80%651K
39.73%-1.07M
-4,460.00%-684K
Cash from discontinued investing activities
Operating cash flow
262.15%29.08M
114.65%16.7M
457.97%85.39M
-8,009.35%-58.96M
162.48%8.2M
76.51%-17.93M
9.25%-114.04M
-3.17%-23.85M
95.74%-727K
48.18%-13.13M
Investing cash flow
Cash flow from continuing investing activities
-107.29%-14.04M
-56.31%32M
98.04%-347K
120.91%34.11M
-248.20%-194.28M
46.57%192.52M
203.01%73.24M
-124.81%-17.75M
109.88%15.44M
-224.27%-55.8M
Net PPE purchase and sale
----
---50K
--0
----
----
----
--0
--0
----
----
Net intangibles purchase and sale
----
---40M
--0
--0
----
----
--0
--0
--0
----
Net investment purchase and sale
-107.29%-14.04M
-1.63%72.05M
98.04%-347K
121.23%34.16M
-176.51%-154.28M
46.57%192.52M
204.66%73.24M
-124.81%-17.75M
109.88%15.44M
-225.12%-55.8M
Cash from discontinued investing activities
Investing cash flow
-107.29%-14.04M
-56.31%32M
98.04%-347K
120.91%34.11M
-248.20%-194.28M
46.57%192.52M
203.01%73.24M
-124.81%-17.75M
109.88%15.44M
-224.27%-55.8M
Financing cash flow
Cash flow from continuing financing activities
-28.85%1.04M
206.49%25.13M
236.68%5.43M
4,342.86%12.75M
42.99%5.48M
-40.58%1.47M
-54.86%8.2M
-63.02%1.61M
-73.08%287K
-23.46%3.83M
Net common stock issuance
-28.85%1.04M
206.49%25.13M
236.68%5.43M
4,342.86%12.75M
42.99%5.48M
-40.58%1.47M
-54.86%8.2M
-63.02%1.61M
-73.08%287K
-23.46%3.83M
Cash from discontinued financing activities
Financing cash flow
-28.85%1.04M
206.49%25.13M
236.68%5.43M
4,342.86%12.75M
42.99%5.48M
-40.58%1.47M
-54.86%8.2M
-63.02%1.61M
-73.08%287K
-23.46%3.83M
Net cash flow
Beginning cash position
61.20%194.43M
-21.27%120.62M
-35.27%103.96M
-20.29%116.06M
40.81%296.67M
-21.27%120.62M
-53.83%153.21M
59.96%160.61M
-46.61%145.6M
-32.09%210.69M
Current changes in cash
-90.86%16.08M
326.50%73.83M
326.26%90.48M
-180.62%-12.09M
-177.46%-180.6M
206.27%176.05M
81.75%-32.6M
-175.74%-39.99M
108.71%15M
-73.44%-65.09M
Effect of exchange rate changes
350.00%5K
-400.00%-18K
-50.00%-12K
-150.00%-4K
--0
-200.00%-2K
-14.29%6K
-900.00%-8K
166.67%8K
300.00%4K
End cash Position
-29.04%210.52M
61.20%194.43M
61.20%194.43M
-35.27%103.96M
-20.29%116.06M
40.81%296.67M
-21.27%120.62M
-21.27%120.62M
59.96%160.61M
-46.61%145.6M
Free cash flow
262.15%29.08M
79.53%-23.35M
457.97%85.39M
-8,016.23%-59.01M
-142.28%-31.8M
76.51%-17.93M
10.05%-114.04M
-3.17%-23.85M
95.74%-727K
48.27%-13.13M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 262.15%29.08M114.65%16.7M457.97%85.39M-8,009.35%-58.96M162.48%8.2M76.51%-17.93M9.25%-114.04M-3.17%-23.85M95.74%-727K48.18%-13.13M
Net income from continuing operations 138.48%16.56M71.62%-61.29M209.76%45.8M-139.77%-65.18M103.28%1.11M61.95%-43.02M-28.66%-215.98M3.18%-41.73M-88.03%-27.18M22.47%-34.01M
Operating gains losses -----29.45%-4.59M--030.94%-1.49M150.30%1.24M-1,180.24%-4.34M-52.08%-3.54M4.87%-1.54M-462.92%-2.16M379.21%497K
Depreciation and amortization 1,197.65%5.53M174.04%5.55M234.76%1.64M240.51%1.72M242.91%1.77M-17.44%426K-39.41%2.03M-8.60%489K-48.63%506K-44.56%515K
Change In working capital -136.03%-5.97M-52.27%18.13M228.66%21.71M-196.11%-10.56M-1,198.92%-9.59M-21.65%16.56M253.04%37.99M-12.43%6.61M156.77%10.98M84.29%-738K
-Change in receivables 131.67%2.27M-1,834.54%-39.27M-12.59%-7.82M-181.36%-10.38M-157.19%-13.91M-485.07%-7.17M115.03%2.26M-88.90%-6.94M229.50%12.75M-197.07%-5.41M
-Change in inventory -3,561.12%-16.65M-1,292.88%-28.81M-4,960.32%-15.07M-1,853.44%-11.22M-574.68%-3M-42.26%481K157.36%2.42M42.86%310K118.03%640K263.73%632K
-Change in prepaid assets -64.28%-3.67M-809.42%-17.69M-171.54%-1.14M-588.63%-14.06M-105.48%-263K-19.91%-2.23M38.40%2.49M118.49%1.6M-228.85%-2.04M108.01%4.8M
-Change in payables and accrued expense -52.09%13.98M224.65%97.97M367.66%43.37M2,431.65%21.66M316.74%3.75M23.86%29.19M399.60%30.18M16.51%9.27M87.22%-929K87.52%-1.73M
-Change in other current assets 1.91%1.76M-12.00%5.74M-57.06%739K5.05%1.71M-5.21%1.56M13.40%1.73M3.51%6.52M15.35%1.72M7.83%1.63M-2.88%1.65M
-Change in other current liabilities 32.50%-3.66M103.42%201K150.69%1.63M262.35%1.73M431.14%2.27M-13.54%-5.43M-64.18%-5.88M-20.80%651K39.73%-1.07M-4,460.00%-684K
Cash from discontinued investing activities
Operating cash flow 262.15%29.08M114.65%16.7M457.97%85.39M-8,009.35%-58.96M162.48%8.2M76.51%-17.93M9.25%-114.04M-3.17%-23.85M95.74%-727K48.18%-13.13M
Investing cash flow
Cash flow from continuing investing activities -107.29%-14.04M-56.31%32M98.04%-347K120.91%34.11M-248.20%-194.28M46.57%192.52M203.01%73.24M-124.81%-17.75M109.88%15.44M-224.27%-55.8M
Net PPE purchase and sale -------50K--0--------------0--0--------
Net intangibles purchase and sale -------40M--0--0----------0--0--0----
Net investment purchase and sale -107.29%-14.04M-1.63%72.05M98.04%-347K121.23%34.16M-176.51%-154.28M46.57%192.52M204.66%73.24M-124.81%-17.75M109.88%15.44M-225.12%-55.8M
Cash from discontinued investing activities
Investing cash flow -107.29%-14.04M-56.31%32M98.04%-347K120.91%34.11M-248.20%-194.28M46.57%192.52M203.01%73.24M-124.81%-17.75M109.88%15.44M-224.27%-55.8M
Financing cash flow
Cash flow from continuing financing activities -28.85%1.04M206.49%25.13M236.68%5.43M4,342.86%12.75M42.99%5.48M-40.58%1.47M-54.86%8.2M-63.02%1.61M-73.08%287K-23.46%3.83M
Net common stock issuance -28.85%1.04M206.49%25.13M236.68%5.43M4,342.86%12.75M42.99%5.48M-40.58%1.47M-54.86%8.2M-63.02%1.61M-73.08%287K-23.46%3.83M
Cash from discontinued financing activities
Financing cash flow -28.85%1.04M206.49%25.13M236.68%5.43M4,342.86%12.75M42.99%5.48M-40.58%1.47M-54.86%8.2M-63.02%1.61M-73.08%287K-23.46%3.83M
Net cash flow
Beginning cash position 61.20%194.43M-21.27%120.62M-35.27%103.96M-20.29%116.06M40.81%296.67M-21.27%120.62M-53.83%153.21M59.96%160.61M-46.61%145.6M-32.09%210.69M
Current changes in cash -90.86%16.08M326.50%73.83M326.26%90.48M-180.62%-12.09M-177.46%-180.6M206.27%176.05M81.75%-32.6M-175.74%-39.99M108.71%15M-73.44%-65.09M
Effect of exchange rate changes 350.00%5K-400.00%-18K-50.00%-12K-150.00%-4K--0-200.00%-2K-14.29%6K-900.00%-8K166.67%8K300.00%4K
End cash Position -29.04%210.52M61.20%194.43M61.20%194.43M-35.27%103.96M-20.29%116.06M40.81%296.67M-21.27%120.62M-21.27%120.62M59.96%160.61M-46.61%145.6M
Free cash flow 262.15%29.08M79.53%-23.35M457.97%85.39M-8,016.23%-59.01M-142.28%-31.8M76.51%-17.93M10.05%-114.04M-3.17%-23.85M95.74%-727K48.27%-13.13M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg